Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on June 24, 2025
The Surgical Energy Instruments Market Analysis 2025 – Insights for Long-Term Investment & Planning
EIN Presswire
·
June 24, 2025
The Business Research Company’s Surgical Energy Instruments Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 24, 2025 /EINPresswire.com/ -- What Is The Growth Trajectory Of The …
Global Transdermal Skin Patches Market Set For 4.9% Growth, Reaching $9.36 Billion By 2029
EIN Presswire
·
June 24, 2025
The Business Research Company’s Transdermal Skin Patches Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 24, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest …
Automated Dispensing Machines Market Growth | USD 10.37 Billion by 2033 Projected 2025-2033
EIN Presswire
·
June 24, 2025
The Automated Dispensing Machines Market is projected to grow from USD 5.37 Bn in 2024 to USD 10.37 Bn by 2033 AUSTIN, TX, UNITED STATES, June 24, 2025 /EINPresswire.com/ -- Automated Dispensing Machines Market Outlook 2025 The Automated Dispensing …
Global Peptide And Oligonucleotide CDMO Market Outlook 2025-2034: Growth Drivers, Share, And Trends
EIN Presswire
·
June 24, 2025
The Business Research Company's Peptide And Oligonucleotide CDMO Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 24, 2025 /EINPresswire.com/ -- The Business Research Company’s …
Pharmacovigilance Outsourcing Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams
EIN Presswire
·
June 24, 2025
The Business Research Company's Pharmacovigilance Outsourcing Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 24, 2025 /EINPresswire.com/ -- The Business Research Company’s …
Online Therapy Services Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams
EIN Presswire
·
June 24, 2025
The Business Research Company's Online Therapy Services Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 24, 2025 /EINPresswire.com/ -- The online therapy services market size …
Innovative Monoclonal Antibody Combo Therapy Boosts Phesgo Market Growth and Oncology Care in 2025
EIN Presswire
·
June 24, 2025
The Business Research Company's Phesgo Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 24, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market …
The Von Willebrand Disease Market Size Forecasts: A Surge To $2.48 Billion By 2029
EIN Presswire
·
June 24, 2025
The Business Research Company’s Von Willebrand Disease Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 24, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest …
Wellness Retreat Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams
EIN Presswire
·
June 24, 2025
The Business Research Company's Wellness Retreat Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 24, 2025 /EINPresswire.com/ -- The Business Research Company’s latest report on …
Presbyopia Prevalence Driving Growth in Vision Correction Solutions and Reading Glasses Market in 2025
EIN Presswire
·
June 24, 2025
The Business Research Company's Reading Glasses Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 24, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
GlobeNewswire
·
June 24, 2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited financial …
Pediatric Dentist Dr. Molly Gunsaulis of Dentistry for Children Shares Expert Insight on Understanding Tongue-Ties and Their Impact in HelloNation
GlobeNewswire
·
June 24, 2025
SPOKANE VALLEY, Wash., June 24, 2025 (GLOBE NEWSWIRE) -- What are the lasting effects of tongue-ties in children, and when should parents seek treatment? Dr. Molly Gunsaulis of Dentistry for Children in Spokane Valley, Washington addresses this in …
SciSparc Announces 1-for-21 Reverse Share Split
GlobeNewswire
·
June 24, 2025
Tel Aviv, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (“SciSparc” or the “Company”) (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central …
Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease
GlobeNewswire
·
June 24, 2025
BOSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
TerrAscend Announces Results of Annual General Meeting
GlobeNewswire
·
June 24, 2025
TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, today announced the results of its annual meeting of shareholders held on June 24, 2025 (the …
Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market
GlobeNewswire
·
June 24, 2025
GAITHERSBURG, Md., June 24, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary
GlobeNewswire
·
June 24, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
NeuroPace Announces Strategic CFO Transition
GlobeNewswire
·
June 24, 2025
Appoints Patrick F. Williams as Chief Financial Officer Williams Brings a Track Record of Leading Medical Device Public Companies as CFO Rebecca Kuhn Departing Company and Will Remain in Advisory Role MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) …
InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke
GlobeNewswire
·
June 24, 2025
MIAMI, June 24, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (the “Company”) (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket …
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress
GlobeNewswire
·
June 24, 2025
CARSON CITY, Nev., June 24, 2025 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver …